AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $989.81M
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.71M
Average 1.38M
Returns on capital
AdaptHealth Corp. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-4.7%
avg -2.7%
ROIC
5.1%
avg 1.4%
ROA
-1.6%
avg -2.3%
Analysis
ROIC is currently the strongest return metric at 5.1% versus its period average of 1.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Suzanne Foster | Chief Executive Officer & Director | USD 2.73M | 56 | 924.05K | 0.68% |
Harriss T. Currie | Chief Financial Officer | USD 1.46M | 64 | 0 | <0.01% |
Jason A. Clemens | Executive Officer | USD 1.46M | 48 | 673.48K | 0.50% |
Russell E. Schuster | Chief Commercial Officer | USD 1.08M | 49 | — | — |
Albert A. Prast | Chief Technology & Innovation Officer | USD 974.62K | 66 | 338.71K | 0.25% |
Christine Archbold | Chief Accounting Officer | USD 602.74K | 52 | — | — |
Luke Montgomery | Senior VP of Investor Relations | — | — | — | — |
Kelly Morgan | Chief Human Resources Officer | — | — | — | — |
Daniel McFadden | Chief Operations Officer | — | 55 | — | — |
Nalin Narayanam | Chief Information Officer | — | — | — | — |
Richard W. Rew | Chief Legal Officer, General Counsel & Secretary | — | 58 | — | — |
Wendy Russalesi | Chief Compliance Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 9, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
16
$49.34M
Sells
3
$278,287.50
Net Transaction Value
+$49.06M
Net buying
Most Active
OEP VII GP, L.L.C.
5 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 7, 26Aug 7, 2026 | WOLF DALE B Indirect | Buy | $117.2K$117,200.00 |
| Aug 6, 26Aug 6, 2026 | WOLF DALE B Direct | Buy | $127.4K$127,400.00 |
| Aug 6, 26Aug 6, 2026 | SAMET KENNETH A Direct | Buy | $149.9K$149,930.00 |
| Aug 6, 26Aug 6, 2026 | WOLF DALE B Direct | Buy | $126K$126,000.00 |
| Jul 1, 26Jul 1, 2026 | Schuster III Russell E. Direct | Sell | $117.7K$117,711.00 |
| Jun 1, 26Jun 1, 2026 | Schuster III Russell E. Direct | Sell | $113.4K$113,426.50 |
| Mar 20, 26Mar 20, 2026 | OEP VII GP, L.L.C. Indirect | Buy | $4.4M$4,431,699.91 |
| Mar 20, 26Mar 20, 2026 | CASHIN RICHARD M JR Indirect | Buy | $4.4M$4,431,699.91 |
| Mar 19, 26Mar 19, 2026 | CASHIN RICHARD M JR Indirect | Buy | $7.2K$7,227.62 |
| Mar 19, 26Mar 19, 2026 | OEP VII GP, L.L.C. Indirect | Buy | $7.2K$7,227.62 |
1–10 of 19
Summary
Insiders reported 16 buys worth $49.34M and 3 sells worth $278,287.50 over the last 12 months. That adds up to net buying of $49.06M. OEP VII GP, L.L.C. was the most active insider with 5 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +3.0% | +14.1% (5yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | -0.7% | +3.1% (5yr)3 analysts |
Analysis
Recent growth has been strongest in Revenue at +3.0% over three years. Forward estimates point to Revenue at +14.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does AdaptHealth Corp. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about AHCO's management, answered from reported figures.
Who manages AHCO?
AdaptHealth Corp. (AHCO) lists 12 active executives. The top listed executive is Luke Montgomery, Senior VP of Investor Relations.
Are AHCO insiders buying or selling?
Recent insider activity shows net buying of $4.36M.
Continue the stock analysis
Jump to another research area for this company.